General Information of Drug (ID: DMH3UGO)

Drug Name
MTX110
Indication
Disease Entry ICD 11 Status REF
Glioma 2A00.0 Phase 1/2 [1]
Cross-matching ID
TTD ID
D0LS8H

References

1 ClinicalTrials.gov (NCT03566199) MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma (PNOC015). U.S. National Institutes of Health.